Skip to main content
NIH
Posted

PAR-25-274

Feasibility Clinical Trials of Mind and Body Interventions for NCCIH High Priority Research Topics (R34 Clinical Trial Required)

Summary

AI-generated

Briefing: PAR-25-274 – Feasibility Clinical Trials of Mind and Body Interventions

Research Focus

This R34 planning grant supports feasibility clinical trials of mind and body interventions—complementary and integrative health approaches with physical and/or psychological therapeutic inputs—for NCCIH high-priority research topics. The funder targets conditions where these nonpharmacologic approaches (e.g., for chronic pain, mild depression, anxiety) are widely used but lack rigorous evidence. Feasibility trials should generate preliminary data to fill critical knowledge gaps necessary to design and justify a subsequent full-scale efficacy, effectiveness, pragmatic, or dissemination and implementation trial. Acceptable aims include assessing intervention acceptability and adherence; tailoring or adapting interventions to specific populations, modalities, or settings; refining protocolized multi-component interventions; determining recruitment and retention feasibility; evaluating randomization procedures; and testing remote delivery modalities. Applications must demonstrate that the proposed R34 work is scientifically necessary and that no similar published or completed pilot studies exist with the same population and intervention.

At-a-Glance

  • Who can apply: Not stated (see full FOA for institution type and investigator stage eligibility)
  • Funding & project length: Not stated
  • Award mechanism: R34 Clinical Trial (planning/feasibility grant)
  • Key dates: Applications due February 20, 2025 (earliest cycle); expiration November 18, 2026; earliest start July 2025
  • Best fit for: Researchers in complementary and integrative health, rehabilitation, behavioral medicine, and pain management seeking to pilot-test mind-body interventions (e.g., mindfulness, yoga, tai chi, acupuncture) before launching larger randomized controlled trials

Note: Applicants are strongly encouraged to contact NCCIH scientific program staff before submission. Applications must use randomized controlled trial design with justified comparator conditions (active control, usual care, sham, or time-and-attention control).

Key Facts

Deadline

Tue, November 17, 2026

Posted

Thu, November 21, 2024

Award / Year (direct costs)

$250,000

Max Total

$500,000

Max Duration

2 years

93.213
Modular
Grants.gov
Agency

Keywords

mind and body interventions
complementary and integrative health
feasibility clinical trials
intervention adaptation
randomized controlled trials
intervention fidelity
outcome measurement
pragmatic trials
dissemination and implementation research
recruitment and retention
chronic pain management
anxiety disorders
depression
nonpharmacologic approaches

Research Areas

MeSH
DiseasesC
Nervous System DiseasesC10Nutritional & Metabolic DiseasesC18Endocrine System DiseasesC19Immune System DiseasesC20Pathological Conditions & SymptomsC23
Analytical/Diagnostic/Therapeutic TechniquesE
DiagnosisE01TherapeuticsE02Anesthesia & AnalgesiaE03Surgical ProceduresE04Investigative TechniquesE05
Psychiatry & PsychologyF
Behavior MechanismsF01Psychological PhenomenaF02Mental DisordersF03Behavioral DisciplinesF04
Phenomena & ProcessesG
MetabolismG03Physiological PhenomenaG07Immune System PhenomenaG12
Disciplines & OccupationsH
Health OccupationsH02
Anthropology/Education/SociologyI
EducationI02Human ActivitiesI03
Health CareN
Health Care ServicesN02Health Care EconomicsN03Health Services AdministrationN04Health Care Quality & EvaluationN05
ANZSRC FoR
Biomedical & Clinical Sciences32
Clinical Sciences3202Neurosciences3209
Health Sciences42
Health Services & Systems4203Public Health4206Sports Science & Exercise4207Traditional & Integrative Medicine4208
Mathematical Sciences49
Statistics4905
Psychology52
Applied & Developmental Psychology5201Clinical & Health Psychology5203

Gotchas (3)

Soft Block
planningprogram study design

R34 mechanism explicitly requires a randomized controlled trial design with at least one intervention arm and one comparator arm; applicants proposing non-randomized or single-arm feasibility studies

AI

95%

Source Text

Investigators should propose a randomized controlled trial design with at least one intervention arm and one comparator arm. There should be strong rationale for the comparator condition (e.g., time and attention control, usual care, standard of care, sham condition, and/or active comparator(s)) based on the research question you plan to address in the future powered trial.

Soft Block
discoverymeta ambiguity

Applications proposing iterative or duplicative studies will be considered of low programmatic relevance and decrease likelihood of funding, but the distinction between necessary feasibility work and

AI

85%

Source Text

Applications should describe and justify the need for feasibility data and ensure that no other published or completed pilot studies have been performed with a similar population and similar intervention. If it is possible to reference successful demonstration of these benchmarks in completed trials or trials currently underway using the proposed or similar intervention and study population, further single-site feasibility work is not needed. Applications proposing such iterative or duplicative

Warning
writingsubmission pre submission

Prior to submission, applicants are strongly encouraged (not just encouraged) to contact NCCIH Scientific/Research contact person; this pre-submission contact appears to be a programmatic expectation

AI

85%

Source Text

Prior to submitting a grant application, NCCIH strongly encourages consulting with NCCIH Scientific/Research extramural program contacts relevant to the area of science for which they are planning to develop an application. Early contact provides an opportunity for NCCIH staff to discuss the scope and goals, and to provide information and guidance.

AI-generated content — verify with the issuing agency’s official FOA/NOFO. Not endorsed by HHS.

© 2026 Biostochastics, Seattle WA · Contact · Terms · About